Article
PON1 L55M polymorphism might contribute to the risk of cancer.
Panminerva medica - 1 Mar 2017
Hu Peizeng, Ma Yongchen, Zhang Lingling, Ma Sheng
Abstract excerpt
INTRODUCTION: The results involved in correlation of PON1 L55M polymorphism and cancer risk are still inconsistent and controversial. Therefore, we performed this comprehensive meta-analysis for the effects of PON1 L55M polymorphism and cancer risk. EVIDENCE ACQUISITION: We carried out a database search in PubMed (Medline) and EMBASE covering all published articles. The strength of association between PON1 L55M...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
